27 completed, 17 unknown, 6 withdrawn, 4 not yet recruiting. 20 Not applicable, 8 Phase 2, 5 Phase 4, 4 Phase 3, 1 Early Phase 1.
Follow Contrast-induced Nephropathy: new trials by email Literature Review of Contrast-induced Nephropathy trials Research Report on Contrast-induced Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 serum creatinine assay - Acute Kidney Injury (Nontraumatic), Contrast-induced Nephropathy | Withdrawn | Maastricht University Medical Center | 2097-11-01 | 2023-10-19 | ||
| Time to Excretion of Contrast, a Maastricht Prospective Observational Study Contrast concentration in urine - Renal Insufficiency, Acute Kidney Injury | Withdrawn | Maastricht University Medical Center | 2097-11-01 | 2023-10-19 | ||
| Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast serum creatinine assay - Renal Insufficiency, Acute Kidney Injury | Withdrawn | Maastricht University Medical Center | 2097-05-01 | 2023-10-19 | ||
| Uric Acid to Albumin Ratio for Predicting Contrast Associated Acute Kidney Injury After Cardiac and Non Cardiac Procedures Contrast-Induced Nephropathy, Acute Kidney Injury | Not yet recruiting | Assiut University | 100 | 2026-11-01 | 2026-10-02 | |
| Contrast Volume as a Predictor of Kidney Injury Following Contrast-Enhanced CT Contrast-Associated Acute Kidney Injury, Acute Kidney Injury | Not yet recruiting | Assiut University | 1112 | 2026-10-01 | 2026-09-10 | |
| Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment No intervention (observational cohort study) - Acute Ischemic Stroke, Contrast-induced Nephropathy | Not yet recruiting | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital | 250 | 2026-04-20 | 2026-04-22 | |
| Role of Amlodipine in Reduction of CIN Calcium channel blocker, Hydration - Contrast-induced Nephropathy | Early Phase 1 | Not yet recruiting | Minia University | 40 | 2025-12-20 | 2025-12-18 |
| Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED Water, %0,9 NaCl - Contrast-Associated Acute Kidney Injury, Contrast-induced Nephropathy | Not applicable | Recruiting | Gaziosmanpasa Research and Education Hospital | 198 | 2025-11-07 | 2026-03-09 |
| Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients. Coenzyme Q10 100 Milligrams Oral Capsule, Placebo - Contrast-induced Nephropathy | Phase 4 | Unknown | Ain Shams University | 250 | 2024-06-15 | 2024-06-28 |
| Contrast Nephropathy Associated FFA use of florescein - Contrast-induced Nephropathy, Acute Kidney Injury | Phase 4 | Unknown | Saglik Bilimleri Universitesi | 140 | 2024-02-01 | 2024-05-17 |
| Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography Continuing Ramipril, Withholding Ramipril - Contrast-Induced Nephropathy, Coronary Angiography | Not applicable | Completed | Tanta University | 44 | 2024-02-01 | 2025-09-22 |
| Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans Acute Kidney Injury, Contrast-induced Nephropathy | Unknown | Changi General Hospital | 5000 | 2023-05-31 | 2024-01-03 | |
| Predictive Value of Osteopontin for Contrast Nephropathy Contrast-induced Nephropathy | Unknown | Noura gamal | 155 | 2022-12-07 | 2022-09-21 | |
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease Preventive treatment with IV-hydration, Preventive treatment with oral hydration - Contrast-induced Nephropathy, Kidney Injury | Not applicable | Recruiting | Odense University Hospital | 254 | 2022-04-20 | 2025-08-01 |
| Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography CE-Iohexol, Iohexol - Contrast-induced Nephropathy | Phase 2 | Withdrawn | Ligand Pharmaceuticals | 2022-01-01 | 2022-04-11 | |
| Clinical Validation of the RENISCHEM L-FABP POC Assay RENISCHEM L-FABP POC Test - Acute Kidney Injury, Contrast-induced Nephropathy | Completed | Hikari Dx, Inc. | 382 | 2021-10-01 | 2026-06-10 | |
| Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury Low-frequency therapeutic ultrasound (LOTUS), LOTUS System with Ultrasound Disabled - Contrast-induced Nephropathy, Chronic Kidney Diseases | Not applicable | Terminated | Sonogenix | 2 | 2021-09-24 | 2023-04-12 |
| Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan ), Hold ACEI or ARBs - Contrast-induced Nephropathy, Chronic Kidney Diseases | Not applicable | Unknown | An-Najah National University | 600 | 2021-06-01 | 2023-06-06 |
| Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3 Isotonic saline, N-acetyl cysteine, Febuxostat 80 MG - Chronic Kidney Disease stage3, Contrast-induced Nephropathy | Not applicable | Completed | Ain Shams University | 120 | 2020-12-01 | 2022-03-25 |
| Effect of Hydration Guided by Vigileo on the Prevention of CIN After PCI for Patients With AMI the adequate hydration group guided by Vigileo - Myocardial Infarction, Contrast-induced Nephropathy | Not applicable | Completed | Chinese PLA General Hospital | 344 | 2020-07-10 | 2023-01-04 |
Showing 20 of 59. Sign in to see all of them.
Acute Kidney Injury (20) · Coronary Artery Disease (8) · Angina, Stable (5) · Renal Insufficiency (5) · Renal Insufficiency, Chronic (3) · Acute Coronary Syndrome (2) · Kidney Failure, Chronic (2) · Acidosis, Lactic (1) · Alzheimer Disease (1) · Angina, Unstable (1) · Aortic Valve Stenosis (1) · Atherosclerosis (1) · Cerebrovascular Disorders (1) · Diabetes Mellitus (1) · Disease (1)
Female Urogenital Diseases (25) · Female Urogenital Diseases and Pregnancy Complications (25) · Male Urogenital Diseases (25) · Urogenital Diseases (25) · Urologic Diseases (25) · Kidney Diseases (24) · Renal Insufficiency (19) · Cardiovascular Diseases (15) · Vascular Diseases (14) · Heart Diseases (13) · Pathological Conditions, Signs and Symptoms (12) · Myocardial Ischemia (11) · Arterial Occlusive Diseases (9) · Arteriosclerosis (9) · Coronary Disease (8)
Sodium Chloride (5) · Acetylcysteine (4) · Atorvastatin (2) · Febuxostat (2) · Iohexol (2) · Ischemic Preconditioning (2) · Ramipril (2) · Allopurinol (1) · Amlodipine (1) · Blood Specimen Collection (1) · Calcium Channel Blockers (1) · Carvedilol (1) · Cholecalciferol (1) · Control Groups (1) · Enalapril (1)
Maastricht University Medical Center (5) · Assiut University (4) · Ain Shams University (2) · Barts & The London NHS Trust (2) · Chinese PLA General Hospital (2) · Derince Training and Research Hospital (2) · I.M. Sechenov First Moscow State Medical University (2) · Isfahan University of Medical Sciences (2) · Alhasan Mujtaba Abdul-Wahid (1) · An-Najah National University (1) · Camilo Andrés Páez Angarita (1) · Central Clinical Hospital of the Russian Academy of Sciences (1) · Changi General Hospital (1) · CyDex Pharmaceuticals, Inc. (1) · Dr. med. Mahir Karakas (1)
United States (8) · Netherlands (6) · Egypt (5) · Iran (4) · Italy (3) · Turkey (Türkiye) (3) · United Kingdom (3) · Canada (2) · China (2) · Estonia (2) · Russia (2) · Singapore (2) · Spain (2) · Colombia (1) · Denmark (1)
Daniel Jones, MRCP, PhD (2) · Keith Marschke, PhD (2) · Alexander Kharlamov, M.D., FESC, FACC, FEACVI (1) · Alexey Sozykin, M.D., D.Sc. (1) · Alhasan Mujtaba, BCPS (1) · Alireza Hajian, M.D. (1) · Amrita Ahluwalia, PhD (1) · Antonio L Bartorelli, MD (1) · Assad H Kata, Ph.D (1) · Chang Yin Chionh, FASN (1) · Dalia R El-Afify, Assoc Prof (1) · Hamid A Abdulsada, Ph.D (1)
PMID 16606801, PMID 16807414, PMID 18702961, PMID 19535188, PMID 22267241, PMID 22815410, PMID 23184900, PMID 24680172, PMID 29785539, PMID 32107605, PMID 33213012, PMID 33346476, PMID 33720573, PMID 33764198, PMID 34733947, PMID 34768464, PMID 36645250, PMID 36747244, PMID 37018968, PMID 37699636, PMID 37772419, PMID 38462389, PMID 38513060, PMID 39584261, PMID 39878152
R01HL132358 (1)